Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02137980 · ClinicalTrials.gov registry record
Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 31,390
- Enrollment target
NCT02137980: Completed study, sponsored by Johns Hopkins University.
NCT02137980 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 31,390 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02137980 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 31,390 participants
- Enrollment target
Study Summary
This is a simple registry of patients undergoing PCI at hospitals without surgery on-site who were participants in the CPORT-E project. The aim of the registry is simple data collection and reporting to respective State Departments of Health. The registry population consists of patients undergoing diagnostic cardiac catheterization for suspected CAD at hospitals without SOS and who require PCI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31,390 participants |
| Start Date | 2011-04-01 |
| Est. Completion | 2016-03 |
What the finished NCT02137980 record still lists
NCT02137980 is an observational study that tracks outcomes without assigning an intervention. Its 31,390 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02137980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02137980 about?
NCT02137980 is a clinical study titled "Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site". This is a simple registry of patients undergoing PCI at hospitals without surgery on-site who were participants in the CPORT-E project. The aim of the registry is simple data collection and reporting to respective State Departments of Health. The registry population consists of patients undergoing d...
What is the current status of trial NCT02137980?
This trial is currently completed. The enrollment target is 31,390 participants. The study started on 2011-04-01. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT02137980?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI